科炬生物 (872334.oc)

+ 收藏

现金流量表(科炬生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年中报2022年年报2022年三季报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 32,679,454.4215,239,718.2538,067,133.5028,996,687.4721,084,742.76
 收到的税费返还(元) --29,293.8425,769.9225,769.92
 收到其他与经营活动有关的现金(元) 3,130,235.19644,582.594,953,057.9520,640,595.237,032,919.21
 经营活动现金流入小计(元) 35,809,689.6115,884,300.8443,049,485.2949,663,052.6228,143,431.89
 购买商品、接受劳务支付的现金(元) 22,019,127.927,328,007.5511,357,426.138,905,243.509,263,175.83
 支付给职工以及为职工支付的现金(元) 23,895,217.1612,448,705.0526,365,493.3818,127,033.9613,225,962.66
 支付的各项税费(元) 1,638,642.33879,519.471,200,861.321,093,717.83227,171.15
 支付其他与经营活动有关的现金(元) 15,161,833.7510,324,071.1114,657,109.0215,771,954.7911,380,461.20
 经营活动现金流出小计(元) 62,714,821.1630,980,303.1853,580,889.8543,897,950.0834,096,770.84
 经营活动产生的现金流量净额平衡项目(元) -----81,100.00
 经营活动产生的现金流量净额(元) -26,905,131.55-15,096,002.34-10,531,404.56--5,953,338.95
二、投资活动产生的现金流量
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 110,155.00110,105.0081,100.0081,100.0081,100.00
 投资活动现金流入小计(元) 110,155.00110,105.0081,100.0081,100.0081,100.00
 购建固定资产、无形资产和其他长期资产支付的现金(元) 455,920.00274,523.002,206,014.562,130,457.561,901,517.56
 投资活动现金流出小计(元) 455,920.00274,523.002,206,014.562,130,457.561,901,517.56
 投资活动产生的现金流量净额(元) -345,765.00-164,418.00-2,124,914.56-2,049,357.56-1,820,417.56
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) 52,800,000.0052,800,000.0043,200,000.00--
 取得借款收到的现金(元) 2,677,000.00877,000.0021,107,495.2821,107,495.2821,107,495.28
 收到其他与筹资活动有关的现金(元) --17,877,105.96--
 筹资活动现金流入小计(元) 55,477,000.0053,677,000.0082,184,601.2421,107,495.2821,107,495.28
 偿还债务支付的现金(元) 21,984,495.2821,984,495.2845,000,000.0022,999,721.3416,000,000.00
 分配股利、利润或偿付利息支付的现金(元) 180,816.90173,399.402,055,263.541,637,277.681,047,532.53
 支付其他与筹资活动有关的现金(元) 4,648,854.114,648,854.1125,765,951.597,129,155.004,964,131.40
 筹资活动现金流出小计(元) 26,814,166.2926,806,748.7972,821,215.1331,766,154.0222,011,663.93
 筹资活动产生的现金流量净额(元) 28,662,833.7126,870,251.219,363,386.11-10,658,658.74-904,168.65
四、汇率变动对现金及现金等价物的影响(元) 33,445.7521,313.6369,841.5163,866.1510,244.71
五、现金及现金等价物净增加额(元) 1,445,382.9111,631,144.50-3,223,091.50-6,879,047.61-8,667,680.45
 加:期初现金及现金等价物余额(元) 7,431,499.327,431,499.3210,654,590.8210,654,590.8210,654,590.82
 期末现金及现金等价物余额(元) 8,876,882.2319,062,643.827,431,499.323,775,543.211,986,910.37
补充资料:
 净利润(元) -23,728,984.55-7,532,177.21-52,540,307.30--15,446,709.06
 资产减值准备(元) 1,312,117.68546,823.56703,012.48--
 固定资产和投资性房地产折旧(元) 2,553,149.621,288,047.832,743,761.19-1,519,481.10
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 2,553,149.621,288,047.832,743,761.19-1,519,481.10
 无形资产摊销(元) 26,625.5012,061.4424,123.71-12,061.68
 长期待摊费用摊销(元) 2,258,085.121,129,042.564,307,891.22-1,791,930.51
 处置固定资产、无形资产和其他长期资产的损失(元) -47,213.42-47,213.42-106,485.12--23,180.53
 固定资产报废损失(元) 754.00665.003,260.46-3,260.46
 财务费用(元) 524,683.23462,648.554,357,962.28-1,955,233.92
 递延所得税(元) --2,281,606.20--8,175.01
  其中:递延所得税资产减少(元) --2,281,606.20--8,175.01
 存货的减少(元) 2,188,561.13-12,354.211,716,191.32--2,762,788.51
 经营性应收项目的减少(元) -3,695,058.53409,052.436,315,568.83--13,869,843.64
 经营性应付项目的增加(元) -16,428,965.34-11,847,769.5213,035,243.26-20,824,821.19
 现金的期末余额(元) 8,876,882.2319,062,643.827,431,499.32-1,986,910.37
 减:现金的期初余额(元) 7,431,499.327,431,499.3210,654,590.82-10,654,590.82
 现金及现金等价物的净增加额(元) 1,445,382.9111,631,144.50-3,223,091.50--8,667,680.45
公告日期 2024-03-152023-08-072023-03-282023-01-102022-08-31
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院